Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
See all open and recent consultations, submissions and decisions at the TGA Consultation hub.
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Advertising (3)
- Scheduling (national classification system) (76)
- Therapeutic goods regulation (18)
- Prescription medicines (15)
- Over the counter (OTC) medicines (14)
- Legislation (12)
- Complementary medicines (11)
- Non-prescription medicines (10)
- Advisory bodies and committees (9)
- Listed medicines (9)
- Labelling and packaging (6)
- Manufacturing (6)
- Medical devices safety (4)
- Biological medicines (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Medicine safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Registered complementary medicines (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Please use the filters or search function to help find relevant consultations.
Search
3 result(s) found, displaying 1 to 3
-
Closed onConsultationThe TGA is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).
-
Closed onConsultationThe outcomes of the public consultation into proposed improvements to the Therapeutic Goods Advertising Code have been published.
-
Closed onConsultationOptions for the reform of the SPF and advertising controls of Schedule 3 medicines. Closing date: 28 April 2017